For the quarter ending 2025-09-30, JAGX has $49,472K in assets. $45,113K in debts. $3,527K in cash and cash equivalents.
| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash | 3,527 | 2,207 | ||
| Accounts receivable, net | 1,437 | 1,173 | ||
| Other receivable | 67 | 143 | ||
| Inventory | 10,628 | 10,719 | ||
| Prepaid expenses and other current assets | 13,743 | 13,661 | ||
| Total current assets | 29,402 | 27,903 | ||
| Total property and equipment at cost | 1,033 | - | ||
| Accumulated depreciation | 550 | - | ||
| Property and equipment, net | 483 | 441 | ||
| Operating lease - right-of-use asset | 1,062 | 1,138 | ||
| Intangible assets, net | 17,285 | 17,545 | ||
| Other assets | 1,240 | 1,241 | ||
| Total assets | 49,472 | 48,268 | ||
| Accounts payable | 8,443 | 6,617 | ||
| Accrued liabilities | 4,175 | 3,603 | ||
| Deferred revenue | 170 | 170 | ||
| Notes payable, net of discount (includes note designated at fair value option amounting to 18.1 million as of september 30, 2025, and 11.9 million as of december 31, 2024, respectively) | 23,108 | 18,572 | ||
| Operating lease liability, current | 226 | 256 | ||
| Total current liabilities | 36,122 | 29,218 | ||
| Deferred revenue, net of current portion | 425 | 468 | ||
| Operating lease liability, net of current portion | 918 | 960 | ||
| Notes payable, net of discount, net of current portion (includes notes designated at fair value option amounting to 10.7 million as of september 30, 2025, and 21.7 million as of december 31, 2024, respectively) | 7,648 | 10,742 | ||
| Total liabilities | 45,113 | 41,388 | ||
| Preferred stock value-Series GConvertible Preferred Stock | 0 | 0 | ||
| Preferred stock value-Series IConvertible Preferred Stock | 0 | 0 | ||
| Preferred stock value-Series MPerpetual Preferred Stock | 0 | 0 | ||
| Preferred stock value-Series NPerpetual Preferred Stock | 0 | - | ||
| Preferred stock value-Series LPerpetual Preferred Stock | 2,485 | 2,485 | ||
| Common stock value-Common Stock Voting | 0 | 0 | ||
| Common stock value-Nonvoting Common Stock | 0 | 0 | ||
| Additional paid-in capital | 380,836 | 373,575 | ||
| Noncontrolling interest | -1,268 | -1,108 | ||
| Accumulated deficit | -376,855 | -367,353 | ||
| Accumulated other comprehensive loss | -839 | -719 | ||
| Total stockholders' equity | 4,359 | 6,880 | ||
| Total liabilities, redeemable preferred stock and stockholders' equity | 49,472 | 48,268 | ||
Jaguar Health, Inc. (JAGX)
Jaguar Health, Inc. (JAGX)